GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could slow tumor growth in rare gut cancers
Disease control OngoingThis study tests a new, easy-to-use injectable drug (CAM2029) against standard monthly shots for people with advanced neuroendocrine tumors of the gut or pancreas. The goal is to see if the new drug can delay tumor growth or death better than current treatments. About 332 adults …
Matched conditions: GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: Camurus AB • Aim: Disease control
Last updated May 26, 2026 10:10 UTC
-
New radiation combo slows aggressive gut tumors in major trial
Disease control OngoingThis phase 3 study tested whether the drug Lutathera, combined with a long-acting hormone therapy (octreotide), can delay tumor growth in people with advanced neuroendocrine tumors of the stomach, intestines, or pancreas. The trial enrolled 226 patients with fast-growing tumors (…
Matched conditions: GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: Advanced Accelerator Applications • Aim: Disease control
Last updated May 26, 2026 10:05 UTC
-
New pill shows promise for rare cancers in early trial
Disease control OngoingThis study tests an experimental oral drug called CVM-1118 in 34 people with advanced neuroendocrine tumors that have not responded to standard treatments. The goal is to see if the drug can slow tumor growth or shrink tumors. Participants take the drug by mouth and are monitored…
Matched conditions: GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC